Lumakras

Merck's early KRAS data suggest combination-friendly safety

Merck showcased its KRAS inhibitor at ESMO, suggesting the drug may be able to overcome some of the challenges that have troubled others in the space.

Annalee Armstrong Oct 23, 2023 9:45am

race runners running sprint marathon catch up

Next round of KRAS drugs follow footsteps of Amgen and Mirati

May 4, 2023 6:00am

airplane divert change block no reject direction oath

AACR: Lilly challenges Amgen, Mirati with early KRAS data

Apr 17, 2023 2:30pm

ship sail explore sea discovery adventure

Sanofi sets Revolution back, sending lead asset to the docks

Dec 8, 2022 7:14am

graphic of a larger shark chomping up a smaller one

Mirati is once again the subject of takeover talks: report

Nov 23, 2022 11:27am

Amgen avoids 'low-hanging fruit' in tackling undruggable targets

Jun 29, 2022 3:00pm